The use of a top-level ontology, e.g. the Basic Formal Ontology (BFO), as a template for a domain ontology is considered a best practice. This saves design efforts and supports multi-disciplinary research. The Drug Discov-ery Investigations ontology (DDI) for automated drug discovery investiga-tions followed the best practices and imported BFO. However not all BFO classes were used. Quality assurance is an important process in the devel-opment of ontologies. One methodology proven to support quality assur-ance is based on automatic derivation of abstraction networks (ANs) from the original ontologies. An AN of an ontology is a compact secondary network summarizing the ontology. ANs were shown to support the identi-fication of sets of concepts with higher concentrations of errors than control sets. In this paper, an AN is derived for the DDI, based on object proper-ties. The top node of this AN represents a set of 81 classes without any object properties. Nodes of an AN representing many classes tend to indi-cate modeling errors. Upon reviewing these 81 classes, we discovered that among them are most of the classes imported from BFO, and that most of these classes are irrelevant for DDI. An algorithm for hiding such irrelevant classes from a specified ontology is described. As many as 18 (56%) of the 32 BFO classes represented by the top node of the AN were hidden from DDI by the algorithm. We conclude that ontologies reusing a top-level ontology should employ this AN-based approach.
|Original language||English (US)|
|Journal||CEUR Workshop Proceedings|
|State||Published - Jan 1 2013|
|Event||4th International Conference on Biomedical Ontology, ICBO 2013 Workshops on International Workshop on Vaccine and Drug Ontology Studies, VDOS 2013 and International Workshop on Definitions in Ontologies, DO 2013 - Part of the Semantic Trilogy 2013 - Montreal, Canada|
Duration: Jul 6 2013 → Jul 12 2013
All Science Journal Classification (ASJC) codes
- Computer Science(all)